Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The United Laboratories International Holdings ( (HK:3933) ) has shared an announcement.
The United Laboratories International Holdings Limited has announced the composition of its board of directors and the roles within its various committees. This announcement highlights the company’s governance structure, which includes a mix of executive and independent non-executive directors, and outlines the leadership of its five key committees, indicating a structured approach to corporate governance.
The most recent analyst rating on (HK:3933) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It is involved in the production and distribution of pharmaceutical products, focusing on providing healthcare solutions.
Average Trading Volume: 17,533,933
Technical Sentiment Signal: Buy
Current Market Cap: HK$32.4B
See more data about 3933 stock on TipRanks’ Stock Analysis page.